Hoyoung Huh, M.D., Ph.D., is chairman of the board of directors for Pliant. In addition to his role at Pliant, Dr. Huh currently serves as chairman to the board of directors for Geron Corporation and CytomX Therapeutics. He is also a director of Eidos Therapeutics and Rezolute. Dr. Huh is the founder of pH Pharma and Healthcare & Humanity Foundation. Previously, he was the CEO of BiPar Sciences, the chairman of Epizyme, and a director of Facet Biotech, Nektar Therapeutics, Addex Therapeutics and EOS, S.p.A (Milano, Italy). Earlier in his career, Dr. Huh was a partner at McKinsey & Company.
He holds a B.A. in biochemistry from Dartmouth College, an M.D. from Cornell University Medical College, and a Ph.D. in cell biology and genetics from Cornell University/Sloan-Kettering Institute.